文献
J-GLOBAL ID:202202291338024700
整理番号:22A0739373
多発性硬化症患者におけるBNT162b2 mRNAワクチンの2用量後のCOVID-19血清学反応に対するクラドリビンの効果【JST・京大機械翻訳】
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
著者 (8件):
Brill Livnat
(Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Jerusalem, Israel)
,
Rechtman Ariel
(Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Jerusalem, Israel)
,
Zveik Omri
(Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Jerusalem, Israel)
,
Haham Nitzan
(Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Jerusalem, Israel)
,
Levin Netta
(Functional Imaging Unit, Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel)
,
Shifrin Alla
(Department of Neurology, Rambam Health Care Campus and Technion Faculty of Medicine, Haifa, Israel)
,
Rozenberg Ayal
(Department of Neurology, Rambam Health Care Campus and Technion Faculty of Medicine, Haifa, Israel)
,
Vaknin-Dembinsky Adi
(Faculty of Medicine, Hebrew University of Jerusalem, Department of Neurology and Laboratory of Neuroimmunology and the Agnes-Ginges Center for Neurogenetics, Hadassah- Medical Center, Jerusalem, Israel)
資料名:
Multiple Sclerosis and Related Disorders
(Multiple Sclerosis and Related Disorders)
巻:
57
ページ:
Null
発行年:
2022年
JST資料番号:
W3397A
ISSN:
2211-0348
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)